Girard Partners Ltd. Biogen Inc. Transaction History

Girard Partners Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 11, 2019	SELL	$278.5 - $352.75 $148,162 - $187,663	-532 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$293.51 - $383.83 $156,147 - $204,197	532 New	532 $187,000
Q1 2018 Apr 18, 2018	SELL	$260.13 - $367.91 $213,566 - $302,054	-821 Closed	0 $0
Q4 2017 Feb 07, 2018	SELL	$307.64 - $344.58 $93,522 - $104,752	-304 Reduced 27.02%	821 $262,000
Q3 2017 Nov 08, 2017	BUY	$281.15 - $329.69 $44,984 - $52,750	160 Added 16.58%	1,125 $352,000
Q2 2017 Aug 08, 2017	BUY	N/A	965	965 $262,000

1,050

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

Stay updated on Girard Partners Ltd. with notifications on news.